95 related articles for article (PubMed ID: 1777175)
1. A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein.
Chapman CJ; Harris JD; Collins MK; Latchman DS
AIDS; 1991 Aug; 5(8):945-50. PubMed ID: 1777175
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
4. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
Di Luca D; Secchiero P; Bovenzi P; Rotola A; Caputo A; Monini P; Cassai E
AIDS; 1991 Sep; 5(9):1095-8. PubMed ID: 1657039
[TBL] [Abstract][Full Text] [Related]
6. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
[TBL] [Abstract][Full Text] [Related]
7. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
8. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
9. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3.
Feng CP; Kulka M; Smith C; Aurelian L
Antisense Nucleic Acid Drug Dev; 1996; 6(1):25-35. PubMed ID: 8783793
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
12. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
13. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
Roebuck KA; Gu DS; Kagnoff MF
AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
[TBL] [Abstract][Full Text] [Related]
14. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
Doppler C; Schalasta G; Amtmann E; Sauer G
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410
[TBL] [Abstract][Full Text] [Related]
15. Activation of the human immunodeficiency virus by herpes simplex virus type 1.
Ostrove JM; Leonard J; Weck KE; Rabson AB; Gendelman HE
J Virol; 1987 Dec; 61(12):3726-32. PubMed ID: 2446005
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Bohne J; Kräusslich HG
FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
[TBL] [Abstract][Full Text] [Related]
18. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat.
Boccuni MC; Campanini F; Battista MC; Bergamini G; Dal Monte P; Ripalti A; Landini MP
AIDS; 1998 Mar; 12(4):365-72. PubMed ID: 9520165
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]